Significant Ownership of Funicular Funds, LP
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for Funicular Funds, LP focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager signature
- /s/ Jacob Ma-Weaver - Jacob Ma-Weaver, Managing Member
- Manager location
- San Francisco, CA
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow Funicular Funds, LP with Pro and return when a new Schedule 13D/G filing changes the record on this page.
Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.
CIK context first
Continue from Funicular Funds, LP
Significant Ownership of Funicular Funds, LP
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| NETD | Nabors Energy Transition Corp. II | Class A Ordinary Shares, $0.0001 par value | 56% | $30,739,247 | -$5,103,000 | 2,710,692 | -14% | Funicular Funds, LP | 17 Nov 2025 |
| SYBX | SYNLOGIC, INC. | Common Stock, par value $0.001 per share | 28% | $2,219,187 | 3,312,219 | 0% | Funicular Funds, LP | 28 Jul 2026 | |
| ATCH | AtlasClear Holdings, Inc. | Common Stock, par value $0.0001 per share | 9.9% | $9,248,539 | +$8,750,331 | 12,669,232 | +1756% | Funicular Funds, LP | 10 Oct 2025 |
| KTTA | Pasithea Therapeutics Corp. | Common Stock, par value $0.0001 | 7.4% | $1,416,424 | 1,839,512 | Funicular Funds, LP | 15 Apr 2026 | ||
| RNTX | Rein Therapeutics, Inc. | Common Stock, par value $0.001 | 6.7% | $6,753,500 | 5,195,000 | Funicular Funds, LP | 01 May 2026 | ||
| IMA | ImageneBio, Inc. | Common Stock, $0.001 par value | 5.8% | $4,211,322 | 643,933 | Funicular Funds, LP | 29 Dec 2025 | ||
| AMWL | American Well Corp | Class A Common Stock, par value $0.01 | 5.5% | $3,951,436 | 810,551 | Funicular Funds, LP | 16 Jan 2026 | ||
| ABEO | ABEONA THERAPEUTICS INC. | Common Stock, par value $0.01 | 5.3% | $14,916,352 | 3,007,329 | Funicular Funds, LP | 27 Mar 2026 | ||
| NSRX | Nasus Pharma Ltd | Ordinary Shares | 5.2% | $3,309,730 | 612,913 | Funicular Funds, LP | 31 Mar 2026 | ||
| ACOG | Alpha Cognition Inc. | Common Stock, no par value | 5.1% | $6,632,745 | +$324,483 | 1,114,747 | +5.1% | Funicular Funds, LP | 11 Feb 2026 |
Schedules 13D/G Reported by Funicular Funds, LP:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.